Article Details

J&J says top drug prospect works across autoimmune disorders - BioPharma Dive

Retrieved on: 2024-02-05 19:03:14

Tags for this article:

Click the tags to see associated articles and topics

J&J says top drug prospect works across autoimmune disorders - BioPharma Dive. View article details on hiswai:

Summary

Johnson & Johnson's experimental drug nipocalimab has shown promise in treating autoimmune diseases like Sjögren's syndrome and generalized myasthenia gravis, with potential for billions in sales. It represents a new class of anti-FcRn therapies.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up